ABK Biomedical's Series A Round

ABK Biomedical raised a round of funding on May 02, 2014. Investors include Wilmington Investor Network.

ABK Biomedical innovates embolic agents and delivery devices. The company is driven by the clinical need to develop integrated solutions to simplify embolotherapy procedures performed by interventiona…

Articles about ABK Biomedical's Series A Round: